Recordati Industria Chimica e Farmaceutica Balance Sheet Health
Financial Health criteria checks 3/6
Recordati Industria Chimica e Farmaceutica has a total shareholder equity of €1.7B and total debt of €1.8B, which brings its debt-to-equity ratio to 106.2%. Its total assets and total liabilities are €4.2B and €2.5B respectively. Recordati Industria Chimica e Farmaceutica's EBIT is €626.6M making its interest coverage ratio 8.9. It has cash and short-term investments of €221.8M.
Key information
106.2%
Debt to equity ratio
€1.79b
Debt
Interest coverage ratio | 8.9x |
Cash | €221.81m |
Equity | €1.69b |
Total liabilities | €2.52b |
Total assets | €4.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0KBS's short term assets (€1.2B) exceed its short term liabilities (€1.0B).
Long Term Liabilities: 0KBS's short term assets (€1.2B) do not cover its long term liabilities (€1.5B).
Debt to Equity History and Analysis
Debt Level: 0KBS's net debt to equity ratio (93.1%) is considered high.
Reducing Debt: 0KBS's debt to equity ratio has increased from 82.6% to 106.2% over the past 5 years.
Debt Coverage: 0KBS's debt is well covered by operating cash flow (27.1%).
Interest Coverage: 0KBS's interest payments on its debt are well covered by EBIT (8.9x coverage).